Eurepa is an oral diabetes medicine designed for people living with type 2 diabetes. It contains two active ingredients, Repaglinide and Metformin, which work together to help the body regulate blood sugar. Repaglinide stimulates the pancreas to release insulin, especially after meals, while Metformin improves the way your body uses insulin and reduces sugar production in the liver. Together, these effects help reduce high blood glucose and maintain better control. The benefits of taking Eurepa include more stable blood sugar control, flexibility with mealtime dosing, and a combined effect from two different drug mechanisms. On our website, Eurepa is available in dosages of 0.5 mg, 1 mg, and 2 mg tablets, so your doctor can tailor the dose to your specific needs.